Murine Models of Germinal Center Derived-lymphomas

Overview

Journal Curr Opin Immunol

Publisher Elsevier

Specialty Allergy & Immunology

Date 2017 Feb 5

PMID 28160624

Citations 11

Authors

Parham Ramezani-Rad

Robert C Rickert

Affiliations

Soon will be listed here.

Abstract

The germinal center (GC) reaction is an adaptive immune response to select B cells bearing high-affinity B cell receptors (BCRs) to undergo further differentiation into antibody-producing cells or memory B cells. To drive affinity maturation, (GC) B cells undergo rounds of hypermutation and rapid proliferation, which can enhance susceptibility to malignant transformation. Lymphomas frequently originate from GC B cells, but the etiology for most lymphoma subtypes is unknown. Work in the past decade has more fully documented the mutational landscape in lymphomas, but the impact of these genomic lesions is often difficult to ascertain. In addition, while mutations affecting BCR signaling are well studied, the impact of extrinsic microenvironmental factors has not been widely addressed. Murine models are useful tools to study lymphomagenesis and disease progression, as well as potential treatment in a pre-clinical setting. Herein we discuss advances in murine models of lymphoma and how they inform on key characteristics of human lymphomas.

Citing Articles

Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1 stem cell-like T cells over PD-1 T cells curbing tumor progression.

Del Rio M, de Juan C, Roncador G, Caleiras E, Alvarez-Esteban R, Perez-Simon J Front Immunol. 2023; 14:1113858.

PMID: 37033927 PMC: 10076739. DOI: 10.3389/fimmu.2023.1113858.

NF-κB signaling in inflammation and cancer.

Zhang T, Ma C, Zhang Z, Zhang H, Hu H MedComm (2020). 2022; 2(4):618-653.

PMID: 34977871 PMC: 8706767. DOI: 10.1002/mco2.104.

A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival.

Lamaison C, Latour S, Helaine N, Le Morvan V, Saint-Vanne J, Mahouche I Blood Adv. 2021; 5(23):5372-5386.

PMID: 34555842 PMC: 9153016. DOI: 10.1182/bloodadvances.2020003949.

Mouse Models of Germinal Center Derived B-Cell Lymphomas.

Meyer S, Koul S, Pasqualucci L Front Immunol. 2021; 12:710711.

PMID: 34456919 PMC: 8387591. DOI: 10.3389/fimmu.2021.710711.

Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.

Mossadegh-Keller N, Brisou G, Beyou A, Nadel B, Roulland S Front Immunol. 2021; 12:683597.

PMID: 34335584 PMC: 8323519. DOI: 10.3389/fimmu.2021.683597.

References

Mandelbaum J, Bhagat G, Tang H, Mo T, Brahmachary M, Shen Q . BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell. 2010; 18(6):568-79. PMC: 3030476. DOI: 10.1016/j.ccr.2010.10.030. View

Pasqualucci L, Dalla-Favera R . SnapShot: diffuse large B cell lymphoma. Cancer Cell. 2014; 25(1):132-132.e1. DOI: 10.1016/j.ccr.2013.12.012. View

Schneider C, Kon N, Amadori L, Shen Q, Schwartz F, Tischler B . FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease. Blood. 2016; 128(5):660-6. PMC: 9709922. DOI: 10.1182/blood-2015-11-684357. View

Alizadeh A, Eisen M, Davis R, Ma C, Lossos I, Rosenwald A . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000; 403(6769):503-11. DOI: 10.1038/35000501. View

Cho S, Raybuck A, Stengel K, Wei M, Beck T, Volanakis E . Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system. Nature. 2016; 537(7619):234-238. PMC: 5161594. DOI: 10.1038/nature19334. View

Vogelstein B, Papadopoulos N, Velculescu V, Zhou S, Diaz Jr L, Kinzler K . Cancer genome landscapes. Science. 2013; 339(6127):1546-58. PMC: 3749880. DOI: 10.1126/science.1235122. View

Oricchio E, Ciriello G, Jiang M, Boice M, Schatz J, Heguy A . Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. J Exp Med. 2014; 211(7):1379-91. PMC: 4076578. DOI: 10.1084/jem.20132120. View

Jellusova J, Cato M, Apgar J, Ramezani-Rad P, Leung C, Chen C . Gsk3 is a metabolic checkpoint regulator in B cells. Nat Immunol. 2017; 18(3):303-312. PMC: 5310963. DOI: 10.1038/ni.3664. View

Boice M, Salloum D, Mourcin F, Sanghvi V, Amin R, Oricchio E . Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells. Cell. 2016; 167(2):405-418.e13. PMC: 5221752. DOI: 10.1016/j.cell.2016.08.032. View

10.

Zhang B, Kracker S, Yasuda T, Casola S, Vanneman M, Homig-Holzel C . Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell. 2012; 148(4):739-51. PMC: 3313622. DOI: 10.1016/j.cell.2011.12.031. View

11.

Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes A . Genetics of follicular lymphoma transformation. Cell Rep. 2014; 6(1):130-40. PMC: 4100800. DOI: 10.1016/j.celrep.2013.12.027. View

12.

Okosun J, Bodor C, Wang J, Araf S, Yang C, Pan C . Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet. 2013; 46(2):176-181. PMC: 3907271. DOI: 10.1038/ng.2856. View

13.

Scott D, Gascoyne R . The tumour microenvironment in B cell lymphomas. Nat Rev Cancer. 2014; 14(8):517-34. DOI: 10.1038/nrc3774. View

14.

Souroullas G, Jeck W, Parker J, Simon J, Liu J, Paulk J . An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nat Med. 2016; 22(6):632-40. PMC: 4899144. DOI: 10.1038/nm.4092. View

15.

Dominguez-Sola D, Kung J, Holmes A, Wells V, Mo T, Basso K . The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. Immunity. 2015; 43(6):1064-74. DOI: 10.1016/j.immuni.2015.10.015. View

16.

Victora G, Dominguez-Sola D, Holmes A, Deroubaix S, Dalla-Favera R, Nussenzweig M . Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood. 2012; 120(11):2240-8. PMC: 3447782. DOI: 10.1182/blood-2012-03-415380. View

17.

Love C, Sun Z, Jima D, Li G, Zhang J, Miles R . The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012; 44(12):1321-5. PMC: 3674561. DOI: 10.1038/ng.2468. View

18.

Sander S, Calado D, Srinivasan L, Kochert K, Zhang B, Rosolowski M . Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell. 2012; 22(2):167-79. PMC: 3432451. DOI: 10.1016/j.ccr.2012.06.012. View

19.

Beguelin W, Teater M, Gearhart M, Fernandez M, Goldstein R, Cardenas M . EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis. Cancer Cell. 2016; 30(2):197-213. PMC: 5000552. DOI: 10.1016/j.ccell.2016.07.006. View

20.

Kwon K, Hutter C, Sun Q, Bilic I, Cobaleda C, Malin S . Instructive role of the transcription factor E2A in early B lymphopoiesis and germinal center B cell development. Immunity. 2008; 28(6):751-62. DOI: 10.1016/j.immuni.2008.04.014. View